FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness

FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness

By

The Associated Press

August 9, 2024, 5:25 PM ET

1 min read

WASHINGTON -- FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness.